Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Sponsors and Collaborators
AIDS Malignancy Clinical Trials Consortium

AIDS Malignancy Clinical Trials Consortium


Continue Reading

National Cancer Institute (NCI)

Contact
Erin G Reid, MD

858-822-5354
 
Principal Investigators
Erin G. Reid, MD
University of California, San Diego
 
William Wachsman, MD
University of California, San Diego
 
ClinicalTrials.gov Identifier
NCT00598169